NOT-HG-04-001: NOTICE OF CLARIFICATION � CENTERS OF EXCELLENCE IN ELSI RESEARCH (CEER)

Department of Health
and Human Services (HHS)

NIH... Turning Discovery Into Health^®

NOTICE OF CLARIFICATION CENTERS OF EXCELLENCE IN ELSI RESEARCH (CEER) RELEASE DATE: November 4, 2003 NOTICE: NOT-HG-04-001 National Human Genome Research Institute (NHGRI) PURPOSE OF THIS NOTICE: Clarify page limit for P50 applications to RFA-HG-03-005. This notice is intended to clarify the instructions in RFA HG-03-005 (http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-03-005.html) for page limitations for Centers of Excellence in ELSI Research (CEER) center grant (P50) applications and exploratory grant (P20) applications. For P50 applications, an expanded page limit of up to 40 pages will be allowed for a description of the research plan (sections a-d of the PHS 398 application form). The description should include the overall theme and aims of the Center, the elements that will comprise the Center and how they will be integrated, as well as specific research aims, design and methodologies, data analysis and dissemination plans. Up to 15 additional pages will be allowed to describe the organizational structure of the Center, management plans, and plans for training activities. Additional pages can be used for the other required sections (e.g. the inclusion of women, minorities and children, and human subjects protections). Each individual section should be clearly labeled. For the P20 applications, the regular PHS 398 instructions should be followed (with a page limit of 25 pages total for sections a-d of the research plan). A list of Frequently Asked Questions regarding the development of CEER applications is available on the NHGRI ELSI website at: http://www.genome.gov/11508763. INQUIRIES: Further inquiries regarding CEER applications or this notice should be addressed to: Elizabeth Thomson, MS, RN, CGC, FAAN Program Director, ELSI Research National Human Genome Research Institute National Institutes of Health 31 Center Drive, Room B2B07 Bethesda, MD 20892-2033 (301)402-4997 (301)402-1950 fax et22s@nih.gov http://www.genome.gov

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices